Micreos
Pre-clinicalMicreos is a platform biotech company dedicated to the discovery and development of recombinant proteins for chronic Dermatology and Oncology conditions. Our engineered endolysin technology quickly kills harmful pathogens while preserving the health enhancing microbiome.
Founded
2006
Focus
Small Molecules
About
Micreos is a platform biotech company dedicated to the discovery and development of recombinant proteins for chronic Dermatology and Oncology conditions. Our engineered endolysin technology quickly kills harmful pathogens while preserving the health enhancing microbiome.
Funding History
2Total raised: $28M
Series B$20MUndisclosedMar 15, 2020
Series A$8MUndisclosedJun 15, 2017
Company Info
TypePrivate
Founded2006
LocationWageningen, Netherlands
StagePre-clinical
Contact
SIMILAR COMPANIES
2-BBB Medicines
Pre-clinical · Leiden
Batavia Biosciences
Pre-clinical · Leiden
Bilthoven Biologicals
Pre-clinical · Bilthoven
Agendia
Pre-clinical · Amsterdam
Alloksys Life Sciences
Phase 2 · Wageningen
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile